Esthesioneuroblastoma in childhood and adolescence: Better prognosis with multimodal treatment?

Strahlentherapie und Onkologie

Volumn 181, Issue 6, 2005, Pages 378-384

  Eich, Hans Theodor ^a   Müller, Rolf Peter ^a   Micke, Oliver ^b   Kocher, Martin ^a   Berthold, Frank ^a   Hero, Barbara ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Chemotherapy; Multimodality therapy; Olfactory neuroblastoma; Pediatric esthesioneuroblastoma; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; TENIPOSIDE; VINCRISTINE; VINDESINE;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DIPLOPIA; DISEASE COURSE; EPISTAXIS; ESTHESIONEUROBLASTOMA; EXOPHTHALMOS; FACE ASYMMETRY; FACE PAIN; FEMALE; HEADACHE; HEARING IMPAIRMENT; HUMAN; MALE; MENTAL DISEASE; MULTIMODALITY CANCER THERAPY; NAUSEA; NOSE OBSTRUCTION; PREOPERATIVE TREATMENT; RETINOPATHY; RETROSPECTIVE STUDY; SMELLING DISORDER; TUMOR GROWTH; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; MALE; NASAL CAVITY; NEOPLASM STAGING; NOSE NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 21044441825     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-005-1362-2     Document Type: Article

References (35)

1. Berger RL, Luc R. L'ésthésioneuroépitheliome olfactif. Bull Assoc Fr Etude Cancer 1924;13:410-20.
2. Berhold F, Hero B. Neuroblastoma. Current drug therapy recommendations as part of the total treatment approach. Drugs 2000;59:1261-77.
3. Biller HF, Lawson W, Sachdev VP, et al. Esthesioneuroblastoma. Surgical treatment without radiation. Laryngoscope 1990;100:1199-201.
4. Bobele GB, Sexauer C, Barnes PA, et al. Esthesioneuroblastoma presenting as an orbital mass in a young child. Med Pediatr Oncol 1994;22:269-73.
5. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastomas: a general review of the cases published since the discovery of the tumor in 1924. Anticancer Res 1997;17:2683-706.
6. Dawe CJ. Neoplasms induced by polyomavirus virus in the upper respiratory tract of mice. In: Muir CS, Shanmugaratnam K, eds. Cancer of the rhinopharynx. Copenhagen: Munksgaard, 1967:179-96.
7. Debus J, Haberer T, Schulz-Ertner D, et al. Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives. Strahlenther Onkol 2000;176:211-6.
8. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001;2:683-90.
9. Dulguerow P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1979-1990. Laryngoscope 1992;102:843-8.
10. Eden BV, Debo RF, Larner JM, et al. Esthesioneuroblastoma. Long-term outcome and patterns of failure - the University of Virginia experience. Cancer 1994;73:2556-62.
11. Eich HT, Hero B, Staar S, et al. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma. Strahlenther Onkol 2003;179:233-40.
12. Eich HT, Staar S, Micke O, et al. Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 2001;49:155-60.
13. Eriksen JG, Bastholt L, Krogdahl AS, et al. Esthesioneuroblastoma. What is the optimal treatment? Acta Oncol 2000;39:231-5.
14. Gul B, Kulacoglu S, Yuksel M, et al. Esthesioneuroblastoma in a young child. Neuosurg Rev 1997;20:59-61.
15. Hirose T, Scheithauer BW, Lopes MB, et al. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer 1996;77:1957-9.
16. Kadish S, Godman M, Wang CC. Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer 1976;37:1571-6.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-84.
18. Kocher M, Maarouf M, Bendel M, et al. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol 2004;180:263-7.
19. Kocsis B, Szekely G, Pap L, et al. Effects of radiation treatment planning and patient fixation on the results of postoperative radiotherapy of childhood medulloblastoma. Strahlenther Onkol 2003;179:854-9.
20. Koike K, Jay G, Hartley JW, et al. Activation of retrovirus in transgenic mice: association with development of olfactory neuroblastomas. J Virol 1990;64:3988-91.
21. Koka VN, Julieron M, Bourhis J, et al. Aesthesioneuroblastoma. J Laryngol Otol 1998;112:628-33.
22. Kortmann RD, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity. Strahlenther Onkol 2003;179:585-97.
23. Kumar M, Fallon RJ, Hill JS, et al. Esthesioneuroblastoma in children. J Pediatr Hematol Oncol 2002;24:482-7.
24. Lochrin C. Esthesioneuroblastoma. Med Pediatr Oncol 1989;17:433-8.
25. McElroy EA, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998;42:1023-7.
26. Morita A, Ebersold MJ, Olsen KD, et al. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993;32:706-14.
27. Nguyen QA, Villablanca JG, Siegel SE, et al. Esthesioneuroblastoma in the pediatric age-group: the role of chemotherapy and autologous bone marrow transplantation. Int J Pediatr Otorhinolaryngol 1996;37:45-52.
28. Nieder C, Andratschke N, Wiedenmann N, et al. Radiotherapy for high-grade gliomas: does altered fractionation improve the outcome? Strahlenther Onkol 2004;180:401-7.
29. Schrenzel MD, Higgins RJ, Hinrichs SH, et al. Type C retroviral expression in spontaneous feline olfactory neuroblastomas. Acta Neuropathol (Berl) 1990;80:547-53.
30. Sheehan JM, Sheehan JP, Jane JA, et al. Chemotherapy for esthesioneuroblastoma. Neurosurg Clin N Am 2000;11:693-701.
31. Skolnik EM, Massari FM, Tenta LT. Olfactory neuroepithelioma. Review of the world literature and presentation of two cases. Arch Otolaryngol 1966;84:644-53.
32. Taxy JB, Bharani NK, Mills SE, et al. The spectrum of olfactory neural tumors: a light-microscopic immunohistochemical and ultrastructural analysis. Am J Surg Pathol 1986;10:687-95.
33. Vollrath M. Chemically induced esthesioneuroblastoma: a cytogenic, cell culture and biochemical investigation with implications for tumor histogenesis. Arch Otorhinolaryngol 1989;246:71-8.
34. World Health Organization. WHO handbook for reporting results of cancer treatment. World Health Organization Offset Publication No. 48. Geneva: World Health Organization, 1979.
35. Zabel A, Thilmann C, Milker-Zabel S, et al. The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Strahlenther Onkol 2002;178:187-91.